Anthony Petrone
Stock Analyst at Mizuho
(3.75)
# 609
Out of 4,905 analysts
186
Total ratings
48.87%
Success rate
7.8%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Neutral | $140 → $135 | $124.42 | +8.50% | 6 | Jul 18, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $105 → $90 | $71.33 | +26.17% | 15 | Jul 16, 2025 | |
| TFX Teleflex | Maintains: Neutral | $150 → $130 | $109.79 | +18.41% | 8 | Jul 16, 2025 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $17 → $18 | $17.78 | +1.27% | 8 | Jul 16, 2025 | |
| RMD ResMed | Maintains: Outperform | $250 → $270 | $261.07 | +3.42% | 16 | Jul 16, 2025 | |
| MDT Medtronic | Maintains: Outperform | $98 → $100 | $89.70 | +11.48% | 7 | Jul 16, 2025 | |
| HOLX Hologic | Maintains: Outperform | $65 → $70 | $63.68 | +9.92% | 9 | Jul 16, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Outperform | $58 → $70 | $42.59 | +64.36% | 7 | Jul 16, 2025 | |
| EMBC Embecta | Maintains: Neutral | $13 → $12 | $10.30 | +16.56% | 3 | Jul 16, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $85 → $87 | $76.56 | +13.64% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $84.03 | +19.01% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $45.65 | +42.39% | 2 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $96.73 | +80.92% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2 | $0.58 | +246.14% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $14.64 | +36.66% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $48.36 | +24.07% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $120 | $87.16 | +37.68% | 9 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $42.23 | +37.34% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $60 | $42.34 | +41.71% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $103.78 | +5.99% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $17.14 | -18.30% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $71.56 | +39.74% | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $74.16 | +41.59% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $125.14 | +99.78% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.65 | +110.68% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $516.12 | -24.44% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $79.75 | -15.99% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $115 | $73.77 | +55.89% | 14 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $92.59 | +89.01% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $7.41 | +237.38% | 3 | May 13, 2020 |
Abbott Laboratories
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $124.42
Upside: +8.50%
The Cooper Companies
Jul 16, 2025
Maintains: Outperform
Price Target: $105 → $90
Current: $71.33
Upside: +26.17%
Teleflex
Jul 16, 2025
Maintains: Neutral
Price Target: $150 → $130
Current: $109.79
Upside: +18.41%
STAAR Surgical Company
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $17.78
Upside: +1.27%
ResMed
Jul 16, 2025
Maintains: Outperform
Price Target: $250 → $270
Current: $261.07
Upside: +3.42%
Medtronic
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $89.70
Upside: +11.48%
Hologic
Jul 16, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $63.68
Upside: +9.92%
Establishment Labs Holdings
Jul 16, 2025
Maintains: Outperform
Price Target: $58 → $70
Current: $42.59
Upside: +64.36%
Embecta
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $10.30
Upside: +16.56%
Edwards Lifesciences
Jul 16, 2025
Maintains: Outperform
Price Target: $85 → $87
Current: $76.56
Upside: +13.64%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $84.03
Upside: +19.01%
Jun 13, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $45.65
Upside: +42.39%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $96.73
Upside: +80.92%
Apr 10, 2025
Initiates: Outperform
Price Target: $2
Current: $0.58
Upside: +246.14%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $14.64
Upside: +36.66%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $48.36
Upside: +24.07%
Mar 28, 2025
Maintains: Outperform
Price Target: $115 → $120
Current: $87.16
Upside: +37.68%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $42.23
Upside: +37.34%
Feb 26, 2025
Maintains: Outperform
Price Target: $70 → $60
Current: $42.34
Upside: +41.71%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $103.78
Upside: +5.99%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $17.14
Upside: -18.30%
May 3, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $71.56
Upside: +39.74%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $74.16
Upside: +41.59%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $125.14
Upside: +99.78%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.65
Upside: +110.68%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $516.12
Upside: -24.44%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $79.75
Upside: -15.99%
Feb 8, 2023
Maintains: Buy
Price Target: $110 → $115
Current: $73.77
Upside: +55.89%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $92.59
Upside: +89.01%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $7.41
Upside: +237.38%